File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Validation of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-31) in Chinese

TitleValidation of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-31) in Chinese
Authors
KeywordsChinese
Construct validation
Health-related quality of life
Morphometric fracture
Osteoporosis
QUALEFFO-31
Issue Date2010
PublisherSpringer-Verlag London Ltd. The Journal's web site is located at http://link.springer.de/link/service/journals/10067/
Citation
Clinical Rheumatology, 2010, v. 29 n. 9, p. 965-972 How to Cite?
AbstractQUALEFFO-31 is a recently developed disease-specific instrument derived from QUALEFFO-41 and intended to have improved efficacy and response rates. We aimed to validate QUALEFFO-31 in Chinese and examine the use of QUALEFFO-31 in clinical practice. This questionnaire was translated into Chinese and applied to 118 case-control pairs aged between 50 and 85 years with prevalent osteoporotic vertebral fractures to evaluate its validity, repeatability, and discriminatory ability. It was also used to evaluate the quality of life (QOL) of 69 case-control trios with prevalent clinical and morphometric fractures. The QOL of all subjects was concurrently assessed using SF-36 for comparison. QUALEFFO-31 had good internal consistency with adequate convergent and discriminatory validity. The median test-retest repeatability ranged from 0.65-0.85. In general, there were good correlations between QUALEFFO-31 and SF-36. ROC curve analysis revealed that QUALEFFO-31 had significant ability to discriminate between clinical fracture subjects versus morphometric fracture subjects and controls. QUALEFFO-31 also demonstrated higher discriminatory capacity for pain. Subjects with clinical vertebral fractures (CVFs) had a significant reduction in QOL compared with other subjects. The QUALEFFO-31 is a useful tool for assessing QOL in Chinese. It was well accepted and significantly predictive of subjects with CVFs. © 2010 Clinical Rheumatology.
Persistent Identifierhttp://hdl.handle.net/10722/144965
ISSN
2014 Impact Factor: 1.696
2014 SCImago Journal Rankings: 0.588
PubMed Central ID
ISI Accession Number ID
Funding AgencyGrant Number
Bone Health Fund of the Hong Kong University Foundation
Osteoporosis Research Fund of the University of Hong Kong
Funding Information:

The authors wish to thank the nursing and technical staff of the Osteoporosis Centre, Department of Medicine, Queen Mary Hospital for their help in carrying out this project. This study was supported by the Bone Health Fund of the Hong Kong University Foundation and Osteoporosis Research Fund of the University of Hong Kong.

References

 

DC FieldValueLanguage
dc.contributor.authorLai, BMHen_HK
dc.contributor.authorTsang, SWYen_HK
dc.contributor.authorLam, CLKen_HK
dc.contributor.authorKung, AWCen_HK
dc.date.accessioned2012-02-21T05:42:38Z-
dc.date.available2012-02-21T05:42:38Z-
dc.date.issued2010en_HK
dc.identifier.citationClinical Rheumatology, 2010, v. 29 n. 9, p. 965-972en_HK
dc.identifier.issn0770-3198en_HK
dc.identifier.urihttp://hdl.handle.net/10722/144965-
dc.description.abstractQUALEFFO-31 is a recently developed disease-specific instrument derived from QUALEFFO-41 and intended to have improved efficacy and response rates. We aimed to validate QUALEFFO-31 in Chinese and examine the use of QUALEFFO-31 in clinical practice. This questionnaire was translated into Chinese and applied to 118 case-control pairs aged between 50 and 85 years with prevalent osteoporotic vertebral fractures to evaluate its validity, repeatability, and discriminatory ability. It was also used to evaluate the quality of life (QOL) of 69 case-control trios with prevalent clinical and morphometric fractures. The QOL of all subjects was concurrently assessed using SF-36 for comparison. QUALEFFO-31 had good internal consistency with adequate convergent and discriminatory validity. The median test-retest repeatability ranged from 0.65-0.85. In general, there were good correlations between QUALEFFO-31 and SF-36. ROC curve analysis revealed that QUALEFFO-31 had significant ability to discriminate between clinical fracture subjects versus morphometric fracture subjects and controls. QUALEFFO-31 also demonstrated higher discriminatory capacity for pain. Subjects with clinical vertebral fractures (CVFs) had a significant reduction in QOL compared with other subjects. The QUALEFFO-31 is a useful tool for assessing QOL in Chinese. It was well accepted and significantly predictive of subjects with CVFs. © 2010 Clinical Rheumatology.en_HK
dc.languageengen_US
dc.publisherSpringer-Verlag London Ltd. The Journal's web site is located at http://link.springer.de/link/service/journals/10067/en_HK
dc.relation.ispartofClinical Rheumatologyen_HK
dc.rightsThe Author(s)en_US
dc.rightsCreative Commons: Attribution 3.0 Hong Kong Licenseen_US
dc.subjectChineseen_HK
dc.subjectConstruct validationen_HK
dc.subjectHealth-related quality of lifeen_HK
dc.subjectMorphometric fractureen_HK
dc.subjectOsteoporosisen_HK
dc.subjectQUALEFFO-31en_HK
dc.subject.meshHealth Surveys-
dc.subject.meshLanguage-
dc.subject.meshOsteoporosis - complications - physiopathology - psychology-
dc.subject.meshQuality of Life - psychology-
dc.subject.meshQuestionnaires-
dc.titleValidation of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-31) in Chineseen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4551/resserv?sid=springerlink&genre=article&atitle=Validation of the quality of life questionnaire of the European foundation for osteoporosis (QUALEFFO-31) in Chinese&title=Clinical Rheumatology&issn=07703198&date=2010-09-01&volume=29&issue=9& spage=965&authors=Billy M. H. Lai, Shirley W. Y. Tsang, Cindy L. K. Lam, <i>et al.</i>en_US
dc.identifier.emailLam, CLK:clklam@hku.hken_HK
dc.identifier.emailKung, AWC:awckung@hku.hken_HK
dc.identifier.authorityLam, CLK=rp00350en_HK
dc.identifier.authorityKung, AWC=rp00368en_HK
dc.description.naturepublished_or_final_versionen_US
dc.identifier.doi10.1007/s10067-010-1495-2en_HK
dc.identifier.pmid20577891-
dc.identifier.pmcidPMC2908749-
dc.identifier.scopuseid_2-s2.0-77956188206en_HK
dc.identifier.hkuros175025-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77956188206&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume29en_HK
dc.identifier.issue9en_HK
dc.identifier.spage965en_HK
dc.identifier.epage972en_HK
dc.identifier.eissn1434-9949en_US
dc.identifier.isiWOS:000280241100003-
dc.publisher.placeUnited Kingdomen_HK
dc.description.otherSpringer Open Choice, 21 Feb 2012en_US
dc.identifier.scopusauthoridLai, BMH=24468678100en_HK
dc.identifier.scopusauthoridTsang, SWY=35182014900en_HK
dc.identifier.scopusauthoridLam, CLK=24755913900en_HK
dc.identifier.scopusauthoridKung, AWC=7102322339en_HK
dc.identifier.citeulike7420244-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats